# CD64 and Antibiotics in Human Sepsis

> **NCT02922998** · — · COMPLETED · sponsor: **University of Ulm** · enrollment: 64 (actual)

## Conditions studied

- Antibiotic Resistant Infection
- Critical Illness
- SIRS
- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02922998
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922998, "CD64 and Antibiotics in Human Sepsis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02922998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*